sleep disorders

ICOSS - In­ter­na­tional COVID Sleep Study

ICOSS - In­ter­na­tional COVID Sleep Study

ICOSS is an international research collaboration project started at 2020 and lead from University of Helsinki. It involves multiple leading researches in the field of Sleep Science from several countries across four continents: Europe, North America, South America and Asia. Aim of the project is to study how COVID-19 pandemic and infection has influenced on sleep, circadian rhythms, fatigue, daytime functioning and health in general adult populations. We are currently recruiting participants to 2021 survey, please find details at Research page.

Migraine and sleep disorders: a systematic review

Migraine and sleep disorders are common and often burdensome chronic conditions with a high prevalence in the general population, and with considerable socio-economic impact and costs. The existence of a relationship between migraine and sleep disorders has been recognized from centuries by clinicians and epidemiological studies. Nevertheless, the exact nature of this association, the underlying mechanisms and interactions are complex and not completely understood.

Sleep disorders in children with incidental pineal cyst on MR. A pilot study

For several years, pineal cysts have been considered an incidental finding on brain MRI's even though research and case reports have shown a possible association of pineal cysts with headaches and sleep disturbances. This pilot study aims to evaluate sleep disorders in school-age children with an incidental pineal cyst in an otherwise normal brain MRI.

Practitioner review: treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities

Background: Sleep disturbances, in particular insomnia, represent a common problem in children with neurodevelopmental disabilities (NDDs). Currently, there are no approved medications for insomnia in children by the US Food and Drug Administration or European Medicines Agency and therefore they are prescribed off-label. We critically reviewed pediatric literature on drugs as well as nonpharmacological (behavioral) interventions used for sleep disturbances in children with NDDs.

Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders

Introduction: Sleep disturbances are highly prevalent in children with neurodevelopmental disabilities. Without appropriate treatment, sleep disorders can become chronic and last for many years. However, there are no sleep medications approved by the United States Food and Drug Administration and only one has been approved by the European Medicines Agency for pediatric insomnia; thus, most medications are prescribed off-label.

Poor Sleep Quality and Its Consequences on Mental Health During the COVID-19 Lockdown in Italy

Background: Coronavirus disease 2019 (COVID-19) seriously affected the whole of
Italy. The extreme virulence and the speed of propagation resulted in restrictions and
home confinement. This change was immediately perceived by people who found
themselves exposed to feelings of uncertainty, fear, anger, stress, and a drastic change
in the diurnal but above all nocturnal lifestyle. For these reasons, we aimed to study
the quality of sleep and its connection to distress levels and to evaluate how lifestyle

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma